Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

2BVN

E. coli EF-Tu:GDPNP in complex with the antibiotic enacyloxin IIa

2BVN の概要
エントリーDOI10.2210/pdb2bvn/pdb
分子名称ELONGATION FACTOR TU, PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER, MAGNESIUM ION, ... (5 entities in total)
機能のキーワードtranslation, elongation factor, gtpase, antibiotic, gtp-binding, phosphorylation
由来する生物種ESCHERICHIA COLI
タンパク質・核酸の鎖数2
化学式量合計88976.83
構造登録者
Parmeggiani, A.,Krab, I.M.,Watanabe, T.,Nielsen, R.C.,Dahlberg, C.,Nyborg, J.,Nissen, P. (登録日: 2005-06-30, 公開日: 2005-09-01, 最終更新日: 2023-12-13)
主引用文献Parmeggiani, A.,Krab, I.M.,Watanabe, T.,Nielsen, R.C.,Dahlberg, C.,Nyborg, J.,Nissen, P.
Enacyloxin Iia Pinpoints a Binding Pocket of Elongation Factor TU for Development of Novel Antibiotics.
J.Biol.Chem., 281:2893-, 2006
Cited by
PubMed Abstract: Elongation factor (EF-) Tu.GTP is the carrier of aminoacyl-tRNA to the programmed ribosome. Enacyloxin IIa inhibits bacterial protein synthesis by hindering the release of EF-Tu.GDP from the ribosome. The crystal structure of the Escherichia coli EF-Tu.guanylyl iminodiphosphate (GDPNP).enacyloxin IIa complex at 2.3 A resolution presented here reveals the location of the antibiotic at the interface of domains 1 and 3. The binding site overlaps that of kirromycin, an antibiotic with a structure that is unrelated to enacyloxin IIa but that also inhibits EF-Tu.GDP release. As one of the major differences, the enacyloxin IIa tail borders a hydrophobic pocket that is occupied by the longer tail of kirromycin, explaining the higher binding affinity of the latter. EF-Tu.GDPNP.enacyloxin IIa shows a disordered effector region that in the Phe-tRNAPhe.EF-Tu (Thermus aquaticus).GDPNP.enacyloxin IIa complex, solved at 3.1 A resolution, is stabilized by the interaction with tRNA. This work clarifies the structural background of the action of enacyloxin IIa and compares its properties with those of kirromycin, opening new perspectives for structure-guided design of novel antibiotics.
PubMed: 16257965
DOI: 10.1074/JBC.M505951200
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (2.3 Å)
構造検証レポート
Validation report summary of 2bvn
検証レポート(詳細版)ダウンロードをダウンロード

246905

件を2025-12-31に公開中

PDB statisticsPDBj update infoContact PDBjnumon